NCT03139305View on ClinicalTrials.gov

Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 24, 2017

Primary Completion Date

February 14, 2018

Study Completion Date

February 28, 2026

Conditions
Obesity
Interventions
DRUG

Glucagon

Low dose intravenous infusion for 72 hours at 12.5 ng/kg/min

DRUG

Glucagon

High dose intravenous infusion for 72 hours at 25 ng/kg/min

DRUG

Placebo

Intravenous infusion of saline for 72 hours

Trial Locations (1)

32804

Translational Research Institute for Metabolism and Diabetes, Orlando

All Listed Sponsors
lead

AdventHealth Translational Research Institute

OTHER